HK Stock Market Move | Beautyfarm Med (02373) continued to rise by over 6%, driving growth through internal and external expansion. Last year, net profit after adjustments is expected to increase by over 40% year-on-year.

BEAUTYFARM MED's stock continued to rise by over 6%, reaching a 6.04% increase to 28.46 Hong Kong dollars, with a trading volume of 9.5031 million Hong Kong dollars. In terms of news, recently, BEAUTYFARM MED announced a positive profit forecast for 2025. The company expects revenue in 2025 to be no less than 3 billion yuan, an increase of at least 16% compared to the previous year; adjusted net profit of no less than 380 million yuan, an increase of at least 40% compared to the previous year; and net profit of no less than 340 million yuan, an increase of at least 34% compared to the previous year. The board of directors believes that the performance improvement is mainly due to accelerated external expansion and strong internal growth momentum. The company pointed out that with the full integration of Nairier into the Beautiful Garden brand matrix, the group's business rapidly penetrated the core cities of the Greater Bay Area and surrounding key areas, achieving a significant increase in market share. The continuous release of integration synergy effects after the acquisition has resulted in Nairier's adjusted net profit margin in the first half of 2025 jumping from 6.5% before the acquisition to 10.4%. In addition, with the unique competitive advantage of its business model moat, the group continuously upgrades its medical business capabilities, with the proportion of high-grossing medical business income steadily increasing in 2025; coupled with the continuous improvement of its refined operational system, the group's net profit margin is steadily rising.